IRCT2016120720514N6
Completed
Phase 2
Evaluation of safety, efficacy and durability of PDO thread lift- EVE & NU series (product of Meditronic Dongjun CO) for facial rejuvenation: An open label, phase 2, before- after, clinical trial.
Aftab Froozan Arya Organization0 sites20 target enrollmentTBD
Conditionsskin rejuvenation.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- skin rejuvenation.
- Sponsor
- Aftab Froozan Arya Organization
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and female subjects 30\-60 years old; willing to lift the face or eyebrow or improvement the nasolabial folds; providing written informed consent and attendance in follow up session. Exclusion criteria: History of any rejuvenated procedure during last years in face area; history of any Botulinum, laser, or intense pulsed light during last 6 month; history of Isotretinoin during last 3 month; collagen vascular disease; any systemic or topical disorders which interfere with process of wound healing; history of any implant in face area; severe cardiac disease or cardiac pacemaker; any active, chronic and recurrent infection; bleeding disorders, coagulopathy, any drugs affect bleeding time; susceptibility to keloids or scar formation; active smoker ( last 2 years); pregnancy/ breast feeding
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Self-administered fentanyl for birthing women.ChildbirthReproductive Health and Childbirth - Childbirth and postnatal careACTRN12609000006246Western Health50
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Polynucleotide on Acne ScarsAcne scarPolynucleotide, Acne scarTCTR20230213003SW HEALTHCARE CO.,LTD27
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Polynucleotide for Facial Rejuvenation in ThailandHealthyPolynucleotide, Facial RejuvenationTCTR20230213002SW HEALTHCARE CO.,LTD25
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Polynucleotide for Periorbital Rejuvenation in ThailandHealthyPolynucleotide, Periorbital RejuvenationTCTR20230214003SW HEALTHCARE CO.,LTD25
Completed
Phase 3
A clinical trial to study the effect of primaquine conventional release tablet and primaquine sustained release tablet in prevention of relapse of plasmodium vivax malaria.CTRI/2010/091/000245Ipca Laboratories Ltd360